Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 8 de 8
Filter
1.
Sci Rep ; 10(1): 10061, 2020 Jun 17.
Article in English | MEDLINE | ID: mdl-32555402

ABSTRACT

An amendment to this paper has been published and can be accessed via a link at the top of the paper.

2.
Microsyst Nanoeng ; 4: 33, 2018.
Article in English | MEDLINE | ID: mdl-31057921

ABSTRACT

Fluorescence-activated droplet sorting (FADS) is one of the most important features provided by droplet-based microfluidics. However, to date, it does not allow to compete with the high-throughput multiplexed sorting capabilities offered by flow cytometery. Here, we demonstrate the use of a dielectrophoretic-based FADS, allowing to sort up to five different droplet populations simultaneously. Our system provides means to select droplets of different phenotypes in a single experimental run to separate initially heterogeneous populations. Our experimental results are rationalized with the help of a numerical model of the actuation of droplets in electric fields providing guidelines for the prediction of sorting designs for upscaled or downscaled microsystems.

3.
Trends Biotechnol ; 35(8): 713-727, 2017 08.
Article in English | MEDLINE | ID: mdl-28633993

ABSTRACT

Most cell studies are performed at a population level, relying on the assumption of a normal distribution of the function and fate of a cell among a population. However, technologies allowing single-cell analysis (SCA) have recently arisen and have led to increasing evidence of cell population heterogeneity and its importance. Tremendous amounts of new data could now be uncovered to redefine our understanding of cell omics. Microfluidics has emerged as a major technological player in this new era and is gradually increasing in use among biology laboratories, mainly due to the single-cell high-throughput handling solutions it offers. In this review, we assess its use and relevance for omics analysis at the single-cell level, with a specific focus on compartment-based microfluidic approaches.


Subject(s)
Lab-On-A-Chip Devices , Microfluidic Analytical Techniques/instrumentation , Microfluidic Analytical Techniques/methods , Animals , Humans
4.
Sci Rep ; 7(1): 1366, 2017 05 02.
Article in English | MEDLINE | ID: mdl-28465615

ABSTRACT

Droplet-based microfluidics is extensively and increasingly used for high-throughput single-cell studies. However, the accuracy of the cell counting method directly impacts the robustness of such studies. We describe here a simple and precise method to accurately count a large number of adherent and non-adherent human cells as well as bacteria. Our microfluidic hemocytometer provides statistically relevant data on large populations of cells at a high-throughput, used to characterize cell encapsulation and cell viability during incubation in droplets.


Subject(s)
High-Throughput Screening Assays/methods , Microfluidic Analytical Techniques , Single-Cell Analysis/methods , Cell Proliferation , Cell Survival , Escherichia coli/isolation & purification , HL-60 Cells , High-Throughput Screening Assays/instrumentation , Humans , Lab-On-A-Chip Devices , Microfluidics , Single-Cell Analysis/instrumentation
5.
PLoS One ; 11(7): e0159094, 2016.
Article in English | MEDLINE | ID: mdl-27416070

ABSTRACT

In cancer research, the accuracy of the technology used for biomarkers detection is remarkably important. In this context, digital PCR represents a highly sensitive and reproducible method that could serve as an appropriate tool for tumor mutational status analysis. In particular, droplet-based digital PCR approaches have been developed for detection of tumor-specific mutated alleles within plasmatic circulating DNA. Such an approach calls for the development and validation of a very significant quantity of assays, which can be extremely costly and time consuming. Herein, we evaluated assays for the detection and quantification of various mutations occurring in three genes often misregulated in cancers: the epidermal growth factor receptor (EGFR), the v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog (KRAS) and the Tumoral Protein p53 (TP53) genes. In particular, commercial competitive allele-specific TaqMan® PCR (castPCR™) technology, as well as TaqMan® and ZEN™ assays, have been evaluated for EGFR p.L858R, p.T790M, p.L861Q point mutations and in-frame deletions Del19. Specificity and sensitivity have been determined on cell lines DNA, plasmatic circulating DNA of lung cancer patients or Horizon Diagnostics Reference Standards. To show the multiplexing capabilities of this technology, several multiplex panels for EGFR (several three- and four-plexes) have been developed, offering new "ready-to-use" tests for lung cancer patients.


Subject(s)
ErbB Receptors/genetics , Multiplex Polymerase Chain Reaction/methods , Proto-Oncogene Proteins p21(ras)/genetics , Tumor Suppressor Protein p53/genetics , DNA Mutational Analysis/methods , DNA, Neoplasm/genetics , Humans , Lung Neoplasms/genetics , Lung Neoplasms/pathology , Mutation , Sensitivity and Specificity
6.
Biomicrofluidics ; 9(3): 034101, 2015 May.
Article in English | MEDLINE | ID: mdl-26015838

ABSTRACT

Droplet-based microfluidic technologies are powerful tools for applications requiring high-throughput, for example, in biochemistry or material sciences. Several systems have been proposed for the high-throughput production of monodisperse emulsions by parallelizing multiple droplet makers. However, these systems have two main limitations: (1) they allow the use of only a single disperse phase; (2) they are based on multiple layer microfabrication techniques. We present here a pipette-and-play solution offering the possibility of manipulating simultaneously 10 different disperse phases on a single layer device. This system allows high-throughput emulsion production using aqueous flow rates of up to 26 ml/h (>110 000 drops/s) leading to emulsions with user-defined complex chemical composition. We demonstrate the multiplex capabilities of our system by measuring the kinetics of ß-galactosidase in droplets using nine different concentrations of a fluorogenic substrate.

7.
Med Sci (Paris) ; 31(2): 180-6, 2015 Feb.
Article in French | MEDLINE | ID: mdl-25744265

ABSTRACT

Genetic markers are now widely used in the clinics, particularly in cancer patient management. Indeed, these tumor markers can help in the diagnosis and prognosis of the disease, and provide valuable information for treatment orientation in the context of personalized medicine. The presence of circulating cell-free tumor DNA (cftDNA) and thus of tumor markers in the blood can be considered to partly avoid the use of solid biopsies. The use of blood samples, as liquid biopsies, is less invasive and described as more representative of tumor heterogeneity. However, cftDNA can be found in blood in low proportion that can vary according to the nature and the progression of the tumor. For these reasons, the use of highly sensitive, specific and ideally quantitative methods for its detection are required. These requirements constituted until recently a technological limit, which now can be overcome thanks to digital PCR. This technology could now become a very efficient and non-invasive tool in oncology, complementary to conventional diagnostic techniques.


Subject(s)
Biomarkers, Tumor/blood , DNA, Neoplasm/blood , Neoplasms/blood , Polymerase Chain Reaction/methods , Animals , Breast Neoplasms/blood , Breast Neoplasms/genetics , Colorectal Neoplasms/blood , Colorectal Neoplasms/genetics , DNA, Neoplasm/isolation & purification , Early Detection of Cancer , Female , Fluorescent Dyes/analysis , Gene Amplification , Genes, erbB-1 , Genes, erbB-2 , Genes, ras , Humans , Lung Neoplasms/blood , Lung Neoplasms/genetics , Male , Neoplasm Recurrence, Local/blood , Neoplasms/genetics , Plasma , Real-Time Polymerase Chain Reaction/methods , Sensitivity and Specificity , Serum , Signal Processing, Computer-Assisted
8.
Phys Rev Lett ; 110(13): 138103, 2013 Mar 29.
Article in English | MEDLINE | ID: mdl-23581378

ABSTRACT

Collective cell motion is observed in a wide range of biological processes. In tumors, physiological gradients of nutrients, growth factors, or even oxygen give rise to gradients of proliferation. We show using fluorescently labeled particles that these gradients drive a velocity field resulting in a cellular flow in multicellular spheroids. Under mechanical stress, the cellular flow is drastically reduced. We describe the results with a hydrodynamic model that considers only convection of the particles by the cellular flow.


Subject(s)
Cell Movement/physiology , Models, Biological , Spheroids, Cellular/cytology , Animals , Carbon Compounds, Inorganic/chemistry , Cell Growth Processes/physiology , Cell Line, Tumor , Colonic Neoplasms/pathology , Culture Media , Dextrans/chemistry , Fluorescent Dyes/chemistry , Hydrodynamics , Mice , Nanoparticles/chemistry , Silicon Dioxide/chemistry , Stress, Mechanical , Sulfides/chemistry
SELECTION OF CITATIONS
SEARCH DETAIL
...